The President's Emergency Plan for AIDS Relief received a waiver from the Trump administration's initial stop-work order for ...
The President's Emergency Plan for AIDS Relief has been the subject of a series of presidential orders and memos that have ...
The landmark U.S. HIV/AIDS initiative gets a limited waiver to resume its work, while USAID staffers refuse to grant ...
While Mission for Essential Drugs & Supplies expects to have their stop-work order lifted for HIV programming, “they are very ...
The biggest loss for Africa under the USAID umbrella will be funding for Pepfar, which is used for HIV-related programmes including prevention, testing and treatment. Through Pepfar, the US ...
USAID Director for Security John Vorhees and ... ensures migrants do not migrate illegally to the U.S. Another program, PEPFAR, the President's Emergency Plan for AIDS Relief, received a waiver ...
The US Agency for International Development (USAID), through PEPFAR, has since 2003 supported several countries in a global HIV/AIDS response. The Department of Health said there are 7.8 million ...
The Trump team mercifully seems to realize that they went too far in going after PEPFAR. The problem is that much of USAID funds programs that cost-effectively save lives, programs that have yet ...
USAID is a key partner of Uganda’s health ... has come via the President’s Emergency Plan for AIDS Relief—or PEPFAR, which purchases and supplies HIV medications for countries in need.
additional USAID funding provided through the aid relief program, PEPFAR, gave communities access to ongoing supplies of antiretroviral drugs. Such support is limited from Uganda's own government ...
PEPFAR, a sprawling multiagency public health ... “It’s very hard to communicate the scope of this,” said one USAID official. “We’re still getting guidance on this from our agency ...
The program, which operates in 70 countries, is on hold as part of the freeze on USAID. If PEPFAR is not re-authorized between 2025 and 2029 and other resources are not found for the HIV response ...